A webcast of the available presentations can be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com, and will be available for 90 days.

Combination therapy with cadonilimab, a first-in-class bispecific antibody targeting both PD-1 and CTLA-4, and chemotherapy offers encouraging antitumor activity and manageable safety as a first-line ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

Weill Cornell Medicine scientists created Cyclone, a simple tool that uses the antiviral drug acyclovir to safely switch genes on or off. The system copies a natural genetic “off switch” found in ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

Oxygen is vital to the body. When levels of oxygen in the blood get too low, serious problems can arise. This can happen as... | Genetics And Genomics ...

This longitudinal genomic profiling dataset links gene expression changes to felzartamab’s mechanism ... many of which are outside of our control and could cause future events or results to differ ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

Research from UChicago dissects how a single genetic switch helps butterflies mimic wing patterns of other species to protect ...

With control of KLF15, scientists may potentially convert our body fat stores to natural furnaces where white fat can be ...

Researchers have shown for the first time that flipping an epigenetic “switch” in specific memory-holding neurons can directly alter memory strength.